Cargando…

Effect of Semaglutide versus placebo on psychotic symptoms and quality of life - a pre-specified secondary analysis of HISTORI: A randomized clinical trial in people with pre-diabetes and schizophrenia

INTRODUCTION: Life expectancy of people with schizophrenia is reduced by 10-20 years compared to the general population. The excess mortality is part due to an increased prevalence of cardiovascular disease, prediabetes and obesity, which are in part due to antipsychotic treatment. Gaining weight is...

Descripción completa

Detalles Bibliográficos
Autores principales: Uhrenholt, N., Ganeshalingam, A., Arnfred, S., Frystyk, J., Gæde, P., Bilenberg, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567870/
http://dx.doi.org/10.1192/j.eurpsy.2022.2064